An initiative launched three years ago to tackle barriers to patient care has made significant progress in improving diabetes outcomes across Southeast Ohio.
Explainer: Novo Nordisk’s two-brand bet, how Ozempic and Wegovy are carving India’s GLP-1 market
While both drugs share the same active ingredient, their positioning, pricing, and regulatory pathways diverge sharply, ...
Locals reported experiencing breathing difficulties, eye irritation and other health issues due to the worsening pollution ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results